1. NF-κB Apoptosis
  2. NF-κB Apoptosis
  3. N-Desmethyldauricine

N-Desmethyldauricine is a NF-κB p65 inhibitor and apoptosis inducer. N-Desmethyldauricine reduces the protein expression level of p65, induces apoptosis, arrests the cell cycle at the G0/G1 phase, attenuates intercellular adhesion, and inhibits the growth of 3D spheroids of triple-negative breast cancer. N-Desmethyldauricine can be used in studies related to triple-negative breast cancer.

For research use only. We do not sell to patients.

N-Desmethyldauricine

N-Desmethyldauricine Chemical Structure

CAS No. : 146763-55-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All NF-κB Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

N-Desmethyldauricine is a NF-κB p65 inhibitor and apoptosis inducer. N-Desmethyldauricine reduces the protein expression level of p65, induces apoptosis, arrests the cell cycle at the G0/G1 phase, attenuates intercellular adhesion, and inhibits the growth of 3D spheroids of triple-negative breast cancer. N-Desmethyldauricine can be used in studies related to triple-negative breast cancer[1].

In Vitro

N-Desmethyldauricine (72 h) potently inhibits the proliferation of human triple-negative breast cancer cell lines SUM159, HCC1937, MDA-MB-231, and MDA-MB-468, with IC50 values ranging from 5.73 μM to 13.16 μM after 72 h of treatment[1].
N-Desmethyldauricine (10-30 μM; 24 h) induces apoptosis in human triple-negative breast cancer SUM159 cells, increasing apoptotic cell percentage to 22.77% at 30 μM after 24 h, and upregulates the proapoptotic protein cleaved-poly-ADP-ribose polymerase 1 in a concentration-dependent manner[1].
N-Desmethyldauricine (10-30 μM; 24 h) arrests the cell cycle of human triple-negative breast cancer SUM159 cells in the G0/G1 phase, with 79.8% of cells in G0/G1 at 30 μM after 24 h, and downregulates the G0/G1 phase-related proteins cyclin-dependent kinase 2 and cyclin D1 in a concentration-dependent manner[1].
N-Desmethyldauricine (10-30 μM; 24 h) suppresses the migration of human triple-negative breast cancer SUM159 cells in a concentration-dependent manner, and downregulates the migration-related protein matrix metallopeptidase 9 in a concentration-dependent manner[1].
N-Desmethyldauricine (10, 20, 40, 60 μM) downregulates the expression of p65, an important subunit of the NF-κB pathway, in human triple-negative breast cancer cells in vitro in a concentration-dependent manner[1].
N-Desmethyldauricine (25-100 μM; 10 days) effectively suppresses the growth of human triple-negative breast cancer SUM159 3D tumor spheroids, with 83% growth inhibition at 100 μM after 10 days of treatment, and reduces cell-cell adhesion in spheroids[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: SUM159, HCC1937, MDA-MB-231, MDA-MB-468
Concentration: Titrated for IC50 determination
Incubation Time: 72 h
Result: Inhibited proliferation of all four cell lines in a concentration-dependent manner, with IC50 values of 5.93 μM (SUM159), 13.16 μM (HCC1937), 7.55 μM (MDA-MB-231), and 5.73 μM (MDA-MB-468).

Apoptosis Analysis[1]

Cell Line: SUM159
Concentration: 10-30 μM (Apoptosis assay); 10, 20, 40, 60 μM (Western Blot)
Incubation Time: 24 h (Apoptosis assay)
Result: Increased the percentage of apoptotic SUM159 cells from 3.75% (untreated) to 5.16% (10 μM), 10.22% (20 μM), and 22.77% (30 μM).
Significantly increased the relative protein level of cleaved-poly-ADP-ribose polymerase 1 in a concentration-dependent manner.

Cell Cycle Analysis[1]

Cell Line: SUM159
Concentration: 10-30 μM (Flow cytometry); 10, 20, 40, 60 μM (Western Blot)
Incubation Time: 24 h (Flow cytometry)
Result: Increased the percentage of SUM159 cells in the G0/G1 phase from 56.22% (untreated) to 67.14% (20 μM) and 79.8% (30 μM).
Significantly decreased the relative protein levels of G0/G1 phase-related proteins cyclin-dependent kinase 2 and cyclin D1 in a concentration-dependent manner.

Cell Migration Assay[1]

Cell Line: SUM159
Concentration: 10-30 μM (Wound healing); 10, 20, 40, 60 μM (Western Blot)
Incubation Time: 24 h (Wound healing)
Result: Reduced the migration rate of SUM159 cells in a concentration-dependent manner after 24 h.
Significantly decreased the relative protein level of migration-related matrix metallopeptidase 9 in a concentration-dependent manner.
Molecular Weight

610.74

Formula

C37H42N2O6

CAS No.
SMILES

COC(C=C(CCN1C)C([C@H]1CC2=CC=C(C=C2)OC3=CC(C[C@@H]4C5=CC(OC)=C(OC)C=C5CCN4)=CC=C3O)=C6)=C6OC

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
N-Desmethyldauricine
Cat. No.:
HY-N18190
Quantity:
MCE Japan Authorized Agent: